Allison Way
Senior Vice President of Corporate Communications and Investor Relations
Replay available
Xeris Biopharma Holdings, Inc. (XERS) Q4 2025 Earnings Call
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) Q4 2025 earnings conference call, held 2026-03-02. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Shannon
Chief Executive Officer
Steve Piper
Chief Financial Officer
David Anselm
Analyst, Piper Sandler
Brandon Foulkes
Analyst, H.C. Wainwright
Chase Knickerbocker
Analyst, Craig-Hallam
Dennis Ding
Analyst, Jefferies
Jason Doerr
Analyst, Opco
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Xeris Biopharma Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.141 Hello, everyone. Thank you for joining us and welcome to the Xeris Biopharma 00:00:05.141 -- 00:00:09.470 fourth quarter 2025 earnings conference call. 00:00:09.470 -- 00:00:13.979 After today's prepared remarks, we will host a question and answer session. 00:00:13.979 -- 00:00:19.994 If you would like to ask a question, please press star one on your telephone keypad. 00:00:19.994 -- 00:00:23.457 To withdraw your question, press star 1 again. 00:00:23.457 -- 00:00:28.862 I will now hand the call over to Allison Way, Senior Vice President 00:00:28.862 -- 00:00:32.024 of Corporate Communications and Investor Relations. 00:00:32.024 -- 00:00:34.226 Please go ahead. 00:00:34.226 -- 00:00:39.831 Thank you, Warren. Good morning, and welcome to the Xerox Biopharma 2025 Full-Year 00:00:39.831 -- 00:00:44.736 Financial Results Conference call. Earlier this morning, we issued a press release detailing 00:00:44.736 -- 00:00:50.453 our 2025 financial and operating results and financial guidance for 2026. 00:00:50.453 -- 00:00:53.658 This press release is available on our website. 00:00:53.658 -- 00:00:58.865 Joining me on the call today is John Shannon, our CEO, and Steve Piper, our CFO. 00:00:58.865 -- 00:01:02.991 Following our prepared remarks, we'll open the call for questions. 00:01:02.991 -- 00:01:07.758 Before we begin, I'd like to remind you that today's discussion will include forward-looking 00:01:07.758 -- 00:01:13.206 statements regarding Xeris' future expectations, plans, strategies, objectives, 00:01:13.206 -- 00:01:17.628 and financial performance. These forward-looking statements are based on management's 00:01:17.628 -- 00:01:21.973 current assumptions and beliefs and are subject to a number of risks and uncertainties 00:01:21...